XLI enters August with an interesting split: short sellers are pulling back while the ETF grinds quietly higher, yet the options market remains structurally defensive relative to most equity instruments.
The short-side retreat is the clearest trend of the past month. Short interest has fallen steadily from around 21 million shares in early July to just over 18.3 million now — a drop of nearly 12% of the free float over 30 days, leaving it at 12% of float. That unwind has run in parallel with the price ticking up 2.1% on the week to $186.40. The borrow market confirms the shift: availability has nearly doubled in a week, rising from roughly 73% to 147%, which means more than one share is now available to lend for every share currently borrowed — a sharp reversal from the tightness seen in late July when availability dipped toward 73%. Cost to borrow is running at a modest 0.56%, down about 7% on the week, and has been drifting lower from the 1% range seen in late June. Nothing in the lending market points to squeeze risk; the picture is one of controlled, deliberate short covering.
Options positioning tells a more cautious story, though less extreme than it looks at first glance. The put/call ratio is running at 2.98 — well above levels seen on most individual equities — but for XLI this is actually slightly below its 20-day average of 3.12, sitting about 0.8 standard deviations beneath that mean. The 52-week high on the PCR reached 5.54, so the current level is far from peak defensiveness. For an industrial-sector ETF used heavily by institutions for macro hedging, a structural PCR above 3 is fairly normal; the directional read here is that protective demand has eased modestly from where it was running through most of July.
The ORTEX short score has nudged lower alongside the short interest decline, dropping from around 66 at the end of July to 62.8 now. The score has traced a clear downward arc over the past two weeks, consistent with the unwinding of short positions rather than a new wave of bearish conviction. The institutional holder base is broad — Morgan Stanley and JPMorgan are the largest reported holders at roughly 7% and 6.4% of shares respectively, with Wells Fargo and Goldman Sachs each holding above 4.5% — a roster that reflects XLI's role as a liquid macro positioning vehicle rather than a fundamentally driven single-stock trade. Several Israeli insurance and provident funds (Menora Mivtachim, Migdal, Harel) also appear in the top holders, a reminder that XLI sees demand across a wide institutional base. UBS Asset Management added 1.24 million shares in the most recent quarter, the largest incremental buy among the top holders.
The key variable to watch is whether short interest continues its steady decline toward the mid-teens on a percentage-of-float basis, or whether macro uncertainty — particularly any fresh data on industrial activity or trade policy — prompts a fresh wave of hedging demand that arrests the unwind.
See the live data behind this article on ORTEX.
Open XLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
